WSE : BIO.WA
$0 (0.0%)
WSE
Jeremy Launders
Biotechnology
Healthcare
BIO.WA
361
PL
PLN
0.10
1.35
0.42
0.02
0.00
$282.52M
1.24
0.56
394.91
0.01
$0.0395
$3.39M
1.52%
3.39%
0.69%
0.53%
81.46
0.10
0.10
3/5
0 Analysts
%
-0.44
7/9
$39.83M
$768.53M
$179.75M
$12.8M
No key metrics data available.
| Name | Title |
|---|---|
| Romuald Apollo Harwas | Member of Management Board |
| Anna Grabowska | Senior Finance Manager |
| Kamila Musnicka | Director of Legal Department |
| Ewelina Romanska | Director of HR & Communication |
| Artur Mroz-Goncalves | Chief Executive Officer and Sales & Marketing Director at Bioton Marketing Agency (BMA) |
| Renata Prokopczyk | Chief Accountant |
| Dariusz Gurtowski | Director of Science & Technology |
| Jeremy Launders | Chief Executive Officer & President of the Management Board |
| Mateusz Patryk Kosecki | Head of Biolek Business Unit & Chief Executive Officer of Biolek Sp. Z O.O. |
| Michal Deptuch | Operations Director |
No votes yet today — be the first to share your view!
About Bioton S.a. (WSE:BIO.WA) Stock
Bioton S.A. operates as a biotechnology company, engaged in the creation, production, distribution, and commercialization of a diverse array of pharmaceuticals, medicinal preparations, and active pharmaceutical ingredients. Its primary focus is on diabetes management, offering products such as recombinant human and conventional insulin, alongside oral anti-diabetic medications. The company's portfolio extends to include dietary supplements, blood glucose monitoring strips, and over-the-counter solutions for diabetics. Key insulin products include Gensulin N, Gensulin R, and Gensulin M30, available in vials and cartridges. Complementing these are advanced delivery and monitoring systems like the GensuPen 2 automatic injection device and the GensuCare glucometer for diabetes monitoring, alon ... gside essential needles. Bioton S.A. distributes its offerings across numerous international markets, including Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. Beyond its core product activities, the company also undertakes advertising, advisory services, and general corporate management. Founded in 1989, its headquarters are situated in Ozarów Mazowiecki, Poland.
Frequently Asked Questions
What is the current Bioton S.a. (BIO.WA) stock price?
Bioton S.a.(WSE:BIO.WA) stock price is $3.845 in the last trading session. During the trading session, BIO.WA stock reached the peak price of $4.7 while $3.65 was the lowest point it dropped to. The percentage change in BIO.WA stock occurred in the recent session was 0.0% while the dollar amount for the price change in BIO.WA stock was $0.
BIO.WA's industry and sector of operation?
The WSE listed BIO.WA is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of BIO.WA?
Romuald Apollo Harwas
| Member of Management Board
Anna Grabowska
| Senior Finance Manager
Kamila Musnicka
| Director of Legal Department
Ewelina Romanska
| Director of HR & Communication
Artur Mroz-Goncalves
| Chief Executive Officer and Sales & Marketing Director at Bioton Marketing Agency (BMA)
How many employees does BIO.WA have?
Number of BIO.WA employees currently stands at 361. BIO.WA operates from ul. Poznanska 12, Ozarów Mazowiecki, MZ 05-850, PL.
Link for BIO.WA official website?
Official Website of BIO.WA is: https://www.bioton.pl
How do I contact BIO.WA?
BIO.WA could be contacted at phone #48 22 721 4000 and can also be accessed through its website. BIO.WA operates from ul. Poznanska 12, Ozarów Mazowiecki, MZ 05-850, PL.
How many shares of BIO.WA are traded daily?
The average number of BIO.WA shares traded daily for last 3 months was 42.66K.
What is the market cap of BIO.WA currently?
The market value of BIO.WA currently stands at $330.15M with its latest stock price at $3.845